Epidemiology of dengue virus in iquitos, Peru 1999 to 2005: Interepidemic and epidemic patterns of transmission

PLoS Neglected Tropical Diseases

Volumn 4, Issue 5, 2010, Pages

  Morrison, Amy C ^a,b   Minnick, Sharon L ^a   Rocha, Claudio ^b   Forshey, Brett M ^b   Stoddard, Steven T ^a   Getis, Arthur ^c   Focks, Dana A ^d   Russell, Kevin L ^b   Olson, James G ^b   Blair, Patrick J ^b   Watts, Douglas M ^b,f   Sihuincha, Moises ^e,g   Scott, Thomas W ^a   Kochel, Tadeusz J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d Infectious Disease Analysis   (United States)

^e Loreto Regional Health Department   (Peru)

^f UNIVERSITY OF TEXAS AT EL PASO   (United States)

^g Hospital de Apoyo Iquitos   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DIAGNOSTIC PROCEDURE; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT MONITORING; PERU; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; SEROTYPE; VIRUS DETECTION; VIRUS TRANSMISSION; ABSENTEEISM; AGE; AGED; BLOOD; COHORT ANALYSIS; DENGUE VIRUS; DISEASE TRANSMISSION; EPIDEMIOLOGY; GEOGRAPHY; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; PYREXIA IDIOPATHICA;

ABSENTEEISM; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENGUE; DENGUE VIRUS; FEMALE; FEVER OF UNKNOWN ORIGIN; GEOGRAPHY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERU; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77955296891     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000670     Document Type: Article

References (41)

1. Monath TP (1994) Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A 91: 2395-2400.
2. Kuno G (1995) Review of the factors modulating dengue transmission. Epidemiol Rev 17: 321-335.
3. Gubler DJ (1997) Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. London, UK: CAB International. pp 1-22.
4. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
5. Gubler DJ (2004) The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis 27: 319-330.
6. Rothman AL, Ennis FA (1999) Immunopathogenesis of Dengue hemorrhagic fever. Virology 257: 1-6.
7. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, et al. (1999) Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354: 1431-1434.
8. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, et al. (2002) Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360: 310-312.
9. Morrison AC, Zielinski-Gutierrez E, Scott TW, Rosenberg R (2008) Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Med 5: e68.
10. Scott TW, Morrison AC (2010) Vector dynamics and transmission of dengue virus: implications for dengue surveillance and prevention strategies: vector dynamics and dengue prevention. Curr Top Microbiol Immunol 338: 115-128.
11. Phillips I, Need J, Escamilla J, Colon E, Sanchez S, et al. (1992) First documented outbreak of dengue in the Peruvian Amazon region. Bull Pan Am Health Organ 26: 201-207.
12. Hayes CG, Phillips IA, Callahan JD, Griebenow WF, Hyams KC, et al. (1996) The epidemiology of dengue virus infection among urban, jungle, and rural populations in the Amazon region of Peru. Am J Trop Med Hyg 55: 459-463.
13. Kochel T, Aguilar P, Felices V, Comach G, Cruz C, et al. (2008) Molecular epidemiology of dengue virus type 3 in Northern South America: 2000-2005. Infect Genet Evol 8: 682-688.
14. Forshey BM, Morrison AC, Cruz C, Rocha C, Vilcarromero S, et al. (2009) Dengue virus serotype 4, northeastern Peru, 2008. Emerg Infect Dis 15: 1815-1818.
15. Getis A, Morrison AC, Gray K, Scott TW (2003) Characteristics of the spatial pattern of the dengue vector, Aedes aegypti, in Iquitos, Peru. Am J Trop Med Hyg 69: 494-505.
16. Morrison AC, Astete H, Chapilliquen F, Ramirez-Prada C, Diaz G, et al. (2004) Evaluation of a sampling methodology for rapid assessment of Aedes aegypti infestation levels in Iquitos, Peru. J Med Entomol 41: 502-510.
17. Morrison AC, Gray K, Getis A, Astete H, Sihuincha M, et al. (2004) Temporal and geographic patterns of Aedes aegypti (Diptera: Culicidae) production in Iquitos, Peru. J Med Entomol 41: 1123-1142.
18. Schneider JR, Morrison AC, Astete H, Scott TW, Wilson ML (2004) Adult size and distribution of Aedes aegypti (Diptera: Culicidae) associated with larval habitats in Iquitos, Peru. J Med Entomol 41: 634-642.
19. INEI (Instituto Nacional de Estadística e Informática) (2008) Censos Nacionales 2007: XI de Población y VI de Vivienda. Lima, Peru.
20. Rocha C, Morrison AC, Forshey BM, Blair PJ, Olson JG, et al. (2009) Comparison of two active surveillance programs for the detection of clinical dengue cases in Iquitos, Peru. Am J Trop Med Hyg 80: 656-660.
21. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
22. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, et al. (1999) A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 61: 412-419.
23. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N (1985) Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22: 250-254.
24. Comach G, Blair PJ, Sierra G, Guzman D, Soler M, et al. (2008) Dengue Virus Infections in a Cohort of Schoolchildren from Maracay, Venezuela: A 2-Year Prospective Study. Vector Borne Zoonotic Dis 9: 87-92.
25. Halstead SB, Marchette NJ (2003) Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii. Am J Trop Med Hyg 69: 5-11.
26. Kuno G (2003) Serodiagnosis of flaviviral infections and vaccinations in humans. Adv Virus Res 61: 3-65.
27. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, et al. (2009) Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. Am J Trop Med Hyg 81: 825-833.
28. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, et al. (1989) An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40: 418-427.
29. Ansari MZ, Shope RE, Malik S (1993) Evaluation of vero cell lysate antigen for the ELISA of flaviviruses. J Clin Lab Anal 7: 230-237.
30. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
31. Scott TW, Morrison AC (2003) Aedes aegypti density and the risk of dengue virus transmission. In: Takken W, Scott TW, eds. Ecological Aspects for Application of Genetically Modified Mosquitoes. Norwell, MA: Kluwer Academic Publishers. pp 187-206.
32. Burke DS, Nisalak A, Johnson DE, Scott RM (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
33. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, et al. (1997) Risk factors in dengue shock syndrome. Am J Trop Med Hyg 56: 566-572.
34. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, et al. (2006) High Seroprevalence of Antibodies Against Dengue Virus in a Prospective Study of Schoolchildren in Managua, Nicaragua. Trop Med Int Health 11: 935-942.
35. Teixeira Mda G, Barreto ML, Costa Mda C, Ferreira LD, Vasconcelos PF, et al. (2002) Dynamics of dengue virus circulation: a silent epidemic in a complex urban area. Trop Med Int Health 7: 757-762.
36. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 40-51.
37. Endy TP, Nisalak A, Chunsuttiwat S, Libraty DH, Green S, et al. (2002) Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 52-59.
38. Gubler D (1992) Dengue. In: Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Boca RatonFL: CRC Press. pp 223-260.
39. Cobos ZM, Gutierrez PV, Garcia MM, Mamani ZE, Fernandez CR, et al. (2004) Estudio serológico y virológico del brote de dengue en la Provincia de Coronel Portillo: Ucayali, Perú (2000-2001). Rev Perú Med Exp Salud Publica 21: 139-145.
40. Harrington LC, Scott TW, Lerdthusnee K, Coleman RC, Costero A, et al. (2005) Dispersal of the dengue vector Aedes aegypti within and between rural communities. Am J Trop Med Hyg 72: 209-220.
41. Kuno G (1997) Factors influencing the transmission of dengue viruses. In: Gubler DJ, Kuno G, eds. Dengue and Dengue Hemorrhagic Fever. New York: CAB International. pp 61-88.